Qube Research & Technologies (QRT)’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.5M | Sell |
225,382
-77,539
| -26% | -$5.69M | 0.02% | 707 |
|
2025
Q1 | $34.6M | Sell |
302,921
-109,338
| -27% | -$12.5M | 0.04% | 387 |
|
2024
Q4 | $20.8M | Buy |
412,259
+353,730
| +604% | +$17.8M | 0.03% | 526 |
|
2024
Q3 | $2.71M | Buy |
+58,529
| New | +$2.71M | ﹤0.01% | 1314 |
|
2024
Q2 | – | Sell |
-143,747
| Closed | -$3.62M | – | 3499 |
|
2024
Q1 | $3.62M | Buy |
+143,747
| New | +$3.62M | 0.01% | 1204 |
|
2023
Q4 | – | Sell |
-2,009
| Closed | -$54.7K | – | 3942 |
|
2023
Q3 | $54.7K | Sell |
2,009
-103,442
| -98% | -$2.82M | ﹤0.01% | 2418 |
|
2023
Q2 | $2.35M | Buy |
105,451
+75,650
| +254% | +$1.68M | 0.01% | 914 |
|
2023
Q1 | $645K | Sell |
29,801
-106,963
| -78% | -$2.32M | ﹤0.01% | 1405 |
|
2022
Q4 | $2.78M | Buy |
136,764
+59,881
| +78% | +$1.22M | 0.01% | 766 |
|
2022
Q3 | $1.97M | Buy |
76,883
+45,079
| +142% | +$1.16M | 0.01% | 884 |
|
2022
Q2 | $756K | Sell |
31,804
-8,762
| -22% | -$208K | 0.01% | 1204 |
|
2022
Q1 | $914K | Sell |
40,566
-1,659
| -4% | -$37.4K | 0.01% | 1198 |
|
2021
Q4 | $836K | Buy |
42,225
+12,560
| +42% | +$249K | 0.01% | 1297 |
|
2021
Q3 | $584K | Buy |
+29,665
| New | +$584K | 0.01% | 1135 |
|
2021
Q2 | – | Sell |
-15,935
| Closed | -$379K | – | 2332 |
|
2021
Q1 | $379K | Buy |
+15,935
| New | +$379K | 0.01% | 1329 |
|
2020
Q3 | – | Sell |
-21,070
| Closed | -$354K | – | 1731 |
|
2020
Q2 | $354K | Buy |
21,070
+8,068
| +62% | +$136K | 0.01% | 1234 |
|
2020
Q1 | $155K | Buy |
+13,002
| New | +$155K | 0.01% | 914 |
|